Most analysts love Anheuser-Busch InBev, which has an average rating of buy. But there's reason to believe the stock may be overvalued at today's price of $48.85 per share. Let's look at the ...

Anheuser-Busch Inbev SA (BUD) stock saw a decline, ending the day at $48.85 which represents a decrease of $-1.08 or -2.16% from the prior close of $49.93. The stock opened at $49.4 and touched a low ...

In an advisory issued Friday, Surgeon General Vivek Murthy recommended that labels on alcoholic beverages be updated to include a warning about the risk of cancer associated with alcohol consumption - ...

Companies like Molson Coors, Anheuser-Busch InBev, and Diageo are investing heavily in zero-proof alternatives, with products like Budweiser Zero, Ritual Zero Proof, and non-alcoholic wines gaining ...

Central Pacific Bank Trust Division raised its position in shares of Anheuser-Busch InBev SA/NV (NYSE:BUD – Free Report) by ...

WASHINGTON, DC (Reuters) – Alcoholic drinks should carry a warning about cancer risks on their label, the U.S. Surgeon ...

The US Surgeon General's advisory on cancer and alcohol sent shares of beverage makers lower, but its effects may be much ...

Publicly traded stocks for beer, wine and spirits companies sank Friday following the U.S. Surgeon General's call for the U.S ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Alcoholic drinks should carry a label warning consumers about their cancer risks, the U.S. Surgeon General said in an ...

WASHINGTON — Alcohol products like beer and wine should carry warnings of their links to cancer, the US surgeon general said, ...

For the companies that brew, ferment, distill, bottle and sell alcohol, the surgeon general's new missive is going down like a poorly worded toast.